"TestotardFBNCI" . _:b674179 . "2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamideSNNCI" . "FugerelFBNCI" . "39811"^^ . . "FlutaminFBNCI" . "TecnoflutFBNCI" . . _:b761970 _:b674172 . "Flutamide"^^ . "39811"^^ . "FLUTAMIDEPTFDA76W6J0943E" . "ProfamidFBNCI" . _:b632792 . _:b761971 _:b674173 . "Fluta-GryFBNCI" . "NiftolidSYNCI" . _:b734786 . "4'-Nitro-3'-trifluoromethylisobutyranilideSNNCI" . _:b733665 _:b734786 . _:b674173 . _:b674174 . "FlutamidePTNCI" . "TafenilFBNCI" . _:b674175 . "FlugerelSYNCI" . _:b674174 . "FlutabeneFBNCI" . "Alpha,alpha,alpha-trifluoro-2-methy-4'-nitro-m-propionotoluidideSNNCI" . "SCH 13521CNNCI" . _:b761976 _:b761977 . "4'-Nitro-3'-trifluoromethylisobutyranilideSYDTPNSC0215876" . "FlutanFBNCI" . "DrogenilFBNCI" . "215876"^^ . _:b761977 . _:b674172 . _:b674175 . _:b674172 . "FlukenFBNCI" . "FlucinomSYNCI" . "FlutaplexFBNCI" . _:b734786 _:b761970 . _:b674173 . "flutamidePTNCI-GLOSSCDR0000045264" . . "FlucinomeFBNCI" . "Hirsutism; Prostate carcinoma"^^ . _:b674176 . _:b674172 . _:b761975 _:b674177 . "FLUTABNCI" . _:b761974 _:b674176 . "Flutamide"^^ . "ApimidFBNCI" . . "An anticancer drug that is a type of antiandrogen.NCI-GLOSS" . "Pharmacologic Substance"^^ . "ChimaxFBNCI" . _:b761971 _:b761972 . "ProstogenatFBNCI" . _:b761970 _:b761971 . _:b761975 _:b761976 . _:b761972 _:b761973 . _:b674178 . _:b761977 _:b674179 . "ProstacurFBNCI" . _:b674177 . _:b761976 _:b674178 . "Congenital adrenal hyperplasia; Prostate cancer"^^ . _:b761973 _:b761974 . "147834"^^ . _:b761974 _:b761975 . . "GrisetinFBNCI" . _:b733665 . "FlutamexFBNCI" . _:b674178 . "76W6J0943E"^^ . "C0016384"^^ . "Organic Chemical"^^ . _:b674179 . _:b674176 . "EuflexFBNCI" . "OncosalFBNCI" . "ProstadirexFBNCI" . "CHEBI:5132"^^ . _:b674177 . "EulexinBRNCI" . "A toluidine derivative and a nonsteroidal antiandrogen that is structurally related to bicalutamide and nilutamide. Flutamide and its more potent active metabolite 2-hydroxyflutamide competitively block dihydrotestosterone binding at androgen receptors, forming inactive complexes which cannot translocate into the cell nucleus. Formation of inactive receptors inhibits androgen-dependent DNA and protein synthesis, resulting in tumor cell growth arrest or transient tumor regression. (NCI04)NCI" . "Flutamide"^^ . "13311-84-7"^^ . "Sch 13521SYDTPNSC0215876" . "FDA"^^ . "C11H11F3N2O3"^^ . "FlutamidePTDCP01895" . _:b674176 . "FlutacanFBNCI" . "EulexineFBNCI" . "ProsticaFBNCI" . _:b674177 . "FlulemFBNCI" . _:b761972 _:b674174 . _:b632792 . _:b674179 . _:b674174 . _:b674173 . _:b674175 . "C509"^^ . _:b761973 _:b674175 . _:b632792 _:b733665 . _:b674178 .